Stock Analiz

Johnson & Johnson (JNJ) stock forecast and price target

Price $285.75 · data as of November 13, 2026

12-month price target

Average target$279.41
Upside / downside−2.2%
Analysts22
ConsensusBuy
Low $190.00Average $279.41High $320.00

Gold marker: average target · white marker: today’s price ($285.75)

Analyst ratings

Strong buy 5Buy 11Hold 6Sell 1Strong sell 0

Earnings and revenue estimates

PeriodEPS estimateEPS growthRevenue estimate
Current fiscal year
ends December 31, 2026
$11.12+3.1%$101.2B
Next fiscal year
ends December 31, 2027
$11.62+4.5%$107.8B
Next quarter
ends December 31, 2026
$2.92+18.5%$26.4B
Quarter after
ends March 31, 2027
$2.67−1.0%$25.6B

Consensus of the analysts covering Johnson & Johnson, updated daily. In the last 30 days 6 estimates were raised and 0 lowered.

Our model vs. Wall Street

Analysts see 2.2% downside over 12 months. Our discounted cash flow model with moderate assumptions puts Johnson & Johnson’s intrinsic value about 39% below today’s market value, and it scores 2.6 out of 5 on our checks. Price targets follow sentiment; a DCF follows cash. When both point the same way the signal is stronger. Try your own assumptions.

Frequently asked questions

What is the Johnson & Johnson stock price target?

The average 12-month target from 22 analysts is $279.41, 2.2% below the current price of $285.75 Targets range from $190.00 to $320.00.

Is Johnson & Johnson a buy according to analysts?

The consensus rating is “Buy” (5 strong buy, 11 buy, 6 hold, 1 sell). Ratings are opinions, not guarantees; this is not investment advice.

How much is Johnson & Johnson expected to earn?

Analysts expect EPS of $11.12 for the fiscal year ending December 31, 2026 and $11.62 the year after.

Analyst consensus estimates and price targets, updated daily. Forecasts can be wrong; this is information, not investment advice.